These somatic LMO2 mutations were identified in 3.7% of paediatric and 5.5% of adult T-ALL patient samples and in the PF-382 and DU.528 T-ALL cell lines, suggesting that these mutations were indeed driver events. Here, LMO2 is linked to acute lymphoblastic leukemia.